Guidant fights for patent rights
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical's Atlas+ HF and Epic HF defibrillators and Frontier pacemaker infringe its RE38,119 E "Mower" patent, Guidant alleges in a suit filed in Wilmington, Del. federal court Feb. 2. Atlas and Epic are expected to be approved by FDA in May (1"The Gray Sheet" Jan. 10, 2004, p. 8). According to a filing by St. Jude with the Securities & Exchange Commission, "the '119 patent is also the subject of a lawsuit between Guidant and Medtronic in the same court." St. Jude intends to "vigorously" defend the allegation...
You may also be interested in...
Guidant Surveys Resynch Pool: Doc Loyalty, Sales Presence Will Rule The Day
Cardiac resynchronization defibrillator procedures, by their inherent complexity, will foster loyalty to a single manufacturer's CRT-D devices, Guidant President and CEO Ron Dollens asserted at JPMorgan's annual healthcare conference in San Francisco Jan. 12
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.